Zydus Lifesciences 관리
관리 기준 확인 3/4
Zydus Lifesciences CEO는 Sharvil Patel, Apr2017 에 임명되었습니다 의 임기는 7.58 년입니다. 총 연간 보상은 ₹ 300.00M, 60% 로 구성됩니다. 60% 급여 및 40% 보너스(회사 주식 및 옵션 포함). 는 ₹ 14.04M 가치에 해당하는 회사 주식의 0.001% 직접 소유합니다. 14.04M. 경영진과 이사회의 평균 재임 기간은 각각 6.5 년과 7.3 년입니다.
주요 정보
Sharvil Patel
최고 경영자
₹300.0m
총 보상
| CEO 급여 비율 | 60.0% |
| CEO 임기 | 7.6yrs |
| CEO 소유권 | 0.001% |
| 경영진 평균 재임 기간 | 6.5yrs |
| 이사회 평균 재임 기간 | 7.3yrs |
최근 관리 업데이트
Recent updates
Zydus Lifesciences Limited (NSE:ZYDUSLIFE) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 15
Here's Why We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Is Well Worth Watching
Sep 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) Business And Shares Still Trailing The Market
Aug 30Zydus Lifesciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 14Zydus Lifesciences Limited's (NSE:ZYDUSLIFE) CEO Compensation Is Looking A Bit Stretched At The Moment
Aug 03Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jul 19Zydus Lifesciences' (NSE:ZYDUSLIFE) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 05Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
Jun 20Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Jun 10Zydus Lifesciences (NSE:ZYDUSLIFE) Will Pay A Smaller Dividend Than Last Year
May 25Does Zydus Lifesciences (NSE:ZYDUSLIFE) Deserve A Spot On Your Watchlist?
Mar 18Earnings Not Telling The Story For Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Shares Rise 28%
Feb 28Analyst Estimates: Here's What Brokers Think Of Zydus Lifesciences Limited (NSE:ZYDUSLIFE) After Its Third-Quarter Report
Feb 12Zydus Lifesciences (NSE:ZYDUSLIFE) Could Easily Take On More Debt
Dec 27Here's Why Zydus Lifesciences (NSE:ZYDUSLIFE) Has Caught The Eye Of Investors
Dec 06With EPS Growth And More, Zydus Lifesciences (NSE:ZYDUSLIFE) Makes An Interesting Case
Aug 23Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
Jul 17We Think Zydus Lifesciences (NSE:ZYDUSLIFE) Can Stay On Top Of Its Debt
Jul 15Zydus Lifesciences' (NSE:ZYDUSLIFE) Upcoming Dividend Will Be Larger Than Last Year's
Jun 24Zydus Lifesciences (NSE:ZYDUSLIFE) Is Increasing Its Dividend To ₹6.00
Jun 10Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Increased To ₹6.00
May 21Zydus Lifesciences (NSE:ZYDUSLIFE) Seems To Use Debt Quite Sensibly
Feb 15CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹43b |
| Jun 30 2024 | n/a | n/a | ₹42b |
| Mar 31 2024 | ₹300m | ₹180m | ₹38b |
| Dec 31 2023 | n/a | n/a | ₹30b |
| Sep 30 2023 | n/a | n/a | ₹28b |
| Jun 30 2023 | n/a | n/a | ₹25b |
| Mar 31 2023 | ₹263m | ₹180m | ₹20b |
| Dec 31 2022 | n/a | n/a | ₹21b |
| Sep 30 2022 | n/a | n/a | ₹20b |
| Jun 30 2022 | n/a | n/a | ₹22b |
| Mar 31 2022 | ₹200m | ₹180m | ₹22b |
| Dec 31 2021 | n/a | n/a | ₹23b |
| Sep 30 2021 | n/a | n/a | ₹23b |
| Jun 30 2021 | n/a | n/a | ₹23b |
| Mar 31 2021 | ₹263m | ₹180m | ₹22b |
| Dec 31 2020 | n/a | n/a | ₹18b |
| Sep 30 2020 | n/a | n/a | ₹17b |
| Jun 30 2020 | n/a | n/a | ₹13b |
| Mar 31 2020 | ₹250m | ₹247m | ₹12b |
| Dec 31 2019 | n/a | n/a | ₹12b |
| Sep 30 2019 | n/a | n/a | ₹14b |
| Jun 30 2019 | n/a | n/a | ₹17b |
| Mar 31 2019 | ₹250m | ₹248m | ₹18b |
| Dec 31 2018 | n/a | n/a | ₹20b |
| Sep 30 2018 | n/a | n/a | ₹20b |
| Jun 30 2018 | n/a | n/a | ₹21b |
| Mar 31 2018 | ₹250m | ₹248m | ₹18b |
보상 대 시장: Sharvil 의 총 보상 ($USD 3.55M )은 Indian 시장( $USD 1.10M ).
보상과 수익: Sharvil 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Sharvil Patel (45 yo)
7.6yrs
테뉴어
₹300,000,000
보상
Dr. Sharvil Pankajbhai Patel has been Managing Director of Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) since April 1, 2017 and previously served as its Joint Managing Director...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD & Executive Director | 7.6yrs | ₹300.00m | 0.0015% ₹ 14.0m | |
| COO & Executive Director | 7.3yrs | ₹140.00m | 0.035% ₹ 330.4m | |
| President & CEO of America | 1.1yrs | 데이터 없음 | 데이터 없음 | |
| Chief Financial Officer | no data | ₹54.31m | 데이터 없음 | |
| Head of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Company Secretary & Compliance Officer | 5.8yrs | ₹2.09m | 데이터 없음 |
6.5yrs
평균 재임 기간
경험이 풍부한 관리: ZYDUSLIFE 의 관리팀은 노련하고 경험 (평균 재직 기간 6.5 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD & Executive Director | 27.3yrs | ₹300.00m | 0.0015% ₹ 14.0m | |
| COO & Executive Director | 7.3yrs | ₹140.00m | 0.035% ₹ 330.4m | |
| Non-Executive Chairman | 29.5yrs | ₹1.20m | 74.98% ₹ 716.0b | |
| Independent Director | 8.5yrs | ₹4.00m | 데이터 없음 | |
| Non-Executive Non-Independent Director | 27.3yrs | ₹4.00m | 0.0012% ₹ 11.1m | |
| Independent Non-Executive Director | 5.9yrs | ₹4.10m | 데이터 없음 | |
| Independent Director | 2yrs | ₹3.50m | 데이터 없음 | |
| Independent Director | 2yrs | ₹3.50m | 데이터 없음 | |
| Independent Director | less than a year | 데이터 없음 | 0.00044% ₹ 4.2m |
7.3yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 이사회: ZYDUSLIFE 의 이사회는 경험(평균 재직 기간 7.3 년)으로 간주됩니다.